Pasar al contenido principal

PAPEL DE LOS MICRORNAS Y LOS EXOSOMAS EN LA INDUCCION DE LA TOLERANCIA ISQUEMICA EN EL CEREBRO

RTI2018-098712-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Experimental and Bioinformatic Insights into the Effects of Epileptogenic Variants on the Function and Trafficking of the GABA Transporter GAT-1

  • Piniella, Dolores
  • Canseco, Ania
  • Vidal, Silvia
  • Xiol, Clara
  • Díaz de Bustamante, Aránzazu
  • Martí-Carrera, Itxaso
  • Armstrong, Judith
  • Bastolla, Ugo
  • Zafra, Francisco
In this article, we identified a novel epileptogenic variant (G307R) of the gene SLC6A1, which encodes the GABA transporter GAT-1. Our main goal was to investigate the pathogenic mechanisms of this variant, located near the neurotransmitter permeation pathway, and compare it with other variants located either in the permeation pathway or close to the lipid bilayer. The mutants G307R and A334P, close to the gates of the transporter, could be glycosylated with variable efficiency and reached the membrane, albeit inactive. Mutants located in the center of the permeation pathway (G297R) or close to the lipid bilayer (A128V, G550R) were retained in the endoplasmic reticulum. Applying an Elastic Network Model, to these and to other previously characterized variants, we found that G307R and A334P significantly perturb the structure and dynamics of the intracellular gate, which can explain their reduced activity, while for A228V and G362R, the reduced translocation to the membrane quantitatively accounts for the reduced activity. The addition of a chemical chaperone (4-phenylbutyric acid, PBA), which improves protein folding, increased the activity of GAT-1WT, as well as most of the assayed variants, including G307R, suggesting that PBA might also assist the conformational changes occurring during the alternative access transport cycle., The work was supported by grants from the Spanish Ministry Science and Innovation (RTI2018-098712-B-I00 to FZ; PID2019-109041GB-C22/10.13039/501100011033 to UB; Ministry of Health, Carlos III/FEDER, PI20/00389 to JA; Ministry of Universities (FPU doctoral fellowship (FPU18/02152) to CX) and by the Recovery, Transformation and Resilience Plan of Madrid Autonomous University, CA1/RSUE/2021-00753 to DP., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors

  • Piniella, Dolores
  • Zafra, Francisco
NMDA-type glutamate receptors (NMDARs) constitute one of the main glutamate (Glu) targets in the central nervous system and are involved in synaptic plasticity, which is the molecular substrate of learning and memory. Hypofunction of NMDARs has been associated with schizophrenia, while overstimulation causes neuronal death in neurodegenerative diseases or in stroke. The function of NMDARs requires coincidental binding of Glu along with other cellular signals such as neuronal depolarization, and the presence of other endogenous ligands that modulate their activity by allosterism. Among these allosteric modulators are zinc, protons and Gly, which is an obligatory co-agonist. These characteristics differentiate NMDARs from other receptors, and their structural bases have begun to be established in recent years. In this review we focus on the crosstalk between Glu and glycine (Gly), whose concentration in the NMDAR microenvironment is maintained by various Gly transporters that remove or release it into the medium in a regulated manner. The GlyT1 transporter is particularly involved in this task, and has become a target of great interest for the treatment of schizophrenia since its inhibition leads to an increase in synaptic Gly levels that enhances the activity of NMDARs. However, the only drug that has completed phase III clinical trials did not yield the expected results. Notwithstanding, there are additional drugs that continue to be investigated, and it is hoped that knowledge gained from the recently published 3D structure of GlyT1 may allow the rational design of more effective new drugs., The work was supported by grants from the Spanish Ministry Science and Innovation (RTI 2018-098712-B-I00 to FZ, and by the Recovery, Transformation and Resilience Plan of Madrid Autonomous University, CA1/RSUE/2021-00753 to DP. The institutional support of Fundación Ramon Areces to CBMSO is also acknowledged. The professional editing service NB Revisions was used for technical preparation of the text prior to submission, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CaMK2rep: A Highly Sensitive Genetically Encoded Biosensor for Monitoring CaMKII Activity in Mammalian Cells

  • Martínez-Blanco, Elena
  • de Andrés, Raquel
  • Baratas-Álvarez, Lucía
  • Díez-Guerra, F.Javier
Accurately monitoring calcium/calmodulin-dependent protein kinase II (CaMKII) activity in cells remains a significant challenge due to the limited sensitivity and narrow dynamic range of existing genetically encoded sensors. Here, we introduce CaMK2rep, a novel phosphorylation-based biosensor that enables robust, specific, and high-sensitivity detection of CaMKII activity. CaMK2rep is designed with two tandem CaMKII consensus sites embedded within the native sequence context of synapsin, and its phosphorylation is detected via a phospho-specific antibody, allowing both biochemical and morphological analyses. We validated CaMK2rep in HeLa cells and cultured hippocampal neurons, demonstrating a near-linear response to CaMKII expression levels and to stimulation intensity, and no detectable cytotoxicity. To complement CaMK2rep measurements, we employed the live-cell CaMKAR (Reyes Gaido, O. E. et al. Sci. Transl. Med. 15, eabq7839 (2023)) reporter to monitor CaMKII activity dynamics. Using both tools, we investigated the role of neurogranin (Ng), a major postsynaptic calmodulin (CaM) binding protein, and obtained consistent evidence supporting a CaM-buffering model in which Ng limits basal CaMKII activation by sequestering CaM. These findings establish CaMK2rep as a sensitive, specific, and versatile biosensor for CaMKII signaling, particularly well-suited for immunoblot-based population analyses. They also illustrate the value of combining orthogonal genetically encoded tools to interrogate complex signaling mechanisms in both physiological and pathological contexts., The author Elena Martínez-Blanco (E.M-B.) received research support from the “Comunidad de Madrid”, in the form of contract PEJD-2018/PRE/BDM-8491. The author Raquel de Andrés (R.A.) received research support from the “Comunidad de Madrid”, a regional public institution, in the form of contracts PEJ-2017-AI/BMD-6017 and PEJD-2019-PRE/BMD-14947. The author Lucía Baratas-Álvarez (L.B-A.) received research support from the “Comunidad de Madrid”, in the form of contract TL-CM PJ 2019 TL-BMD-13238. E.M-B., R.A. and L.B-A. were supported by the “Fundación Severo Ochoa”, a private organization ascribed to the Center for Molecular Biology (CSIC-UAM). The present work was initially supported by the Spanish Ministry of Science, Innovation and Universities (grant RTI2018-098712-B-I00).